JONATHAN SILVERSTEIN
CIK 1171005 · last filed 2020-10-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$353.62M
Companies
12
Total Filings
49
Lifetime Open-Market Net
-$235.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 4,267,564 | $24.38 | $104.04M | $21.90M | 3 | 2020-10-06 |
| Adicet Bio, Inc. (TORC) Delisted | Director | 4,297,054 | — | — | $8.00M | 3 | 2020-06-05 |
| AVEDRO INC (AVDR) Delisted | Director | 0 | $24.25 | $0 | $0 | 3 | 2019-11-25 |
| GKOS | Director | 66,790 | $126.81 | $8.47M | -$104.42M | 11 | 2018-03-06 |
| scPharmaceuticals Inc. (SCPH) Delisted | Director | 2,576,532 | $5.67 | $14.61M | $0 | 1 | 2017-11-21 |
| Roka BioScience, Inc. (ROKA) Delisted | Director | 2,273,070 | — | — | $4.60M | 4 | 2016-09-23 |
| BOLD | Director | 4,435,538 | $1.41 | $6.25M | $500.0K | 2 | 2016-08-25 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 1,121,583 | $19.00 | $21.31M | -$174.29M | 16 | 2015-11-27 |
| Relypsa Inc (RLYP) Delisted | Director | 3,810,642 | — | — | $7.83M | 1 | 2013-11-20 |
| NxStage Medical, Inc. (NXTM) Delisted | Director | — | — | — | $0 | 3 | 2010-05-28 |
| PODD | Director | 1,568,841 | $149.70 | $234.86M | $0 | 1 | 2007-05-18 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 2,374,190 | — | — | $0 | 1 | 2007-03-05 |
Recent Filings · Page 5 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-09 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | +1,654 | $0 | EDGAR |
| 2013-04-11 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Exer (M) | +649 | $0 | EDGAR |
| 2012-11-20 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-10-16 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | +2,150,634 | $5.00M | EDGAR |
| 2010-05-28 | NxStage Medical, Inc. (NXTM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-06-01 | NxStage Medical, Inc. (NXTM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-07-24 | NxStage Medical, Inc. (NXTM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-18 | PODD | Conv (C) | +1,568,841 | $0 | EDGAR |
| 2007-03-05 | AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Grant (A) | +44,248 | $0 | EDGAR |
Showing 41–49 of 49
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.